157 related articles for article (PubMed ID: 7622258)
1. Dicloxacillin and flucloxacillin: pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administration.
Røder BL; Frimodt-Møller N; Espersen F; Rasmussen SN
Infection; 1995; 23(2):107-12. PubMed ID: 7622258
[TBL] [Abstract][Full Text] [Related]
2. Re: B. L. Røder, et al.: Dicloxacillin and flucloxacillin: pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administration (Infection 23 [1995] 107-112).
Thijssen HH
Infection; 1996; 24(3):272. PubMed ID: 8811373
[No Abstract] [Full Text] [Related]
3. Safety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses.
Wu G; Zheng Y; Zhou H; Hu X; Liu J; Zhai Y; Zhu M; Wu L; Shentu J
Drug Des Devel Ther; 2015; 9():5687-95. PubMed ID: 26527863
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of cloxacillin, dicloxacillin and flucloxacillin in dental alveolar serum and mandibular bone.
Köndell PA; Nord CE; Nordenram A
Int J Oral Surg; 1982 Feb; 11(1):40-3. PubMed ID: 6811456
[TBL] [Abstract][Full Text] [Related]
5. Dicloxacillin and flucloxacillin twice daily with probenecid in staphylococcal infections. A clinical and pharmakokinetic evaluation.
Hedström SA; Kahlmeter G
Scand J Infect Dis; 1980; 12(3):221-5. PubMed ID: 7433922
[TBL] [Abstract][Full Text] [Related]
6. Optimization of high-performance liquid chromatographic analysis for isoxazolyl penicillins using factorial design.
Hung CT; Lim JK; Zoest AR; Lam FC
J Chromatogr; 1988 Mar; 425(2):331-41. PubMed ID: 3372647
[TBL] [Abstract][Full Text] [Related]
7. Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin.
Sutherland R; Croydon EA; Rolinson GN
Br Med J; 1970 Nov; 4(5733):455-60. PubMed ID: 5481218
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and bioavailability of flucloxacillin in elderly hospitalized patients.
Gath J; Charles B; Sampson J; Smithurst B
J Clin Pharmacol; 1995 Jan; 35(1):31-6. PubMed ID: 7751411
[TBL] [Abstract][Full Text] [Related]
9. Total flucloxacillin plasma concentrations poorly reflect unbound concentrations in hospitalized patients with Staphylococcus aureus bacteraemia.
Chin PKL; Drennan PG; Gardiner SJ; Zhang M; Dalton SC; Chambers ST; Begg EJ
Br J Clin Pharmacol; 2018 Oct; 84(10):2311-2316. PubMed ID: 29908071
[TBL] [Abstract][Full Text] [Related]
10. Dicloxacillin and cloxacillin: pharmacokinetics in healthy and hemodialysis subjects.
Nauta EH; Mattie H
Clin Pharmacol Ther; 1976 Jul; 20(1):98-108. PubMed ID: 1277730
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing the biological inactivation of high protein bound beta-lactam antibiotics in vitro.
Henning C; Bergholm AM; Holm S
APMIS; 1988 Nov; 96(11):997-1001. PubMed ID: 3196479
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and distribution of flucloxacillin in pacemaker patients.
Anderson P; Bluhm G; Ehrnebo M; Herngren L; Jacobson B
Eur J Clin Pharmacol; 1985; 27(6):713-9. PubMed ID: 3987776
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics at two dose levels and pharmacodynamic profiling of flucloxacillin.
Landersdorfer CB; Kirkpatrick CM; Kinzig-Schippers M; Bulitta JB; Holzgrabe U; Drusano GL; Sörgel F
Antimicrob Agents Chemother; 2007 Sep; 51(9):3290-7. PubMed ID: 17576847
[TBL] [Abstract][Full Text] [Related]
14. The simplified oral flucloxacillin absorption test: an accurate method to identify patients with inadequate oral flucloxacillin absorption.
Dijkmans AC; Kweekel DM; Balmforth C; van Esdonk MJ; van Dissel JT; Burggraaf J; Kamerling IMC
Neth J Med; 2019 Sep; 77(7):255-260. PubMed ID: 31582580
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic modelling of total and unbound flucloxacillin in non-critically ill patients to devise a rational continuous dosing regimen.
Wilkes S; van Berlo I; Ten Oever J; Jansman F; Ter Heine R
Int J Antimicrob Agents; 2019 Mar; 53(3):310-317. PubMed ID: 30472288
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of flucloxacillin and cloxacillin in healthy subjects and patients on chronic intermittent haemodialysis.
Nauta EH; Mattie H
Br J Clin Pharmacol; 1975 Apr; 2(2):111-21. PubMed ID: 1234495
[TBL] [Abstract][Full Text] [Related]
17. Plasma concentration following oral administration of di- and flucloxacillin in infants and children.
Bergdahl S; Eriksson M; Finkel Y
Pharmacol Toxicol; 1987 Mar; 60(3):233-4. PubMed ID: 3588519
[TBL] [Abstract][Full Text] [Related]
18. How to calculate clearance of highly protein-bound drugs during continuous venovenous hemofiltration demonstrated with flucloxacillin.
Meyer B; Ahmed el Gendy S; Delle Karth G; Locker GJ; Heinz G; Jaeger W; Thalhammer F
Kidney Blood Press Res; 2003; 26(2):135-40. PubMed ID: 12771540
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics and dosing of flucloxacillin in preterm and term neonates.
Pullen J; de Rozario L; Stolk LM; Degraeuwe PL; van Tiel FH; Zimmermann LJ
Ther Drug Monit; 2006 Jun; 28(3):351-8. PubMed ID: 16778719
[TBL] [Abstract][Full Text] [Related]
20. Relationship between penicillinase production and the in-vitro activity of methicillin, oxacillin, cloxacillin, dicloxacillin, flucloxacillin, and cephalothin against strains of Staphylococcus aureus of different phage patterns and penicillinase activity.
Frimodt-Møller N; Rosdahl VT; Sørensen G; Hartzen SH; Bentzon MW
J Antimicrob Chemother; 1986 Jul; 18(1):27-33. PubMed ID: 3489704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
